Biopsy Devices Market Analysis By Product (Needle Based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles, Biopsy Curettes and Punches) And Segment Forecasts To 2020
The global market for biopsy devices is expected to reach USD 2,335.1 million by 2020 growing at a CAGR of 6.4%. Growing global prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period. Other drivers of this market include the introduction of technological advancements such as robotic biopsy guidance systems and healthcare reforms pertaining to reimbursement policies. Growing patient awareness levels and the presence of high unmet medical needs in emerging markets such as India and China are also expected to fuel future growth of the market.
Biopsy guidance systems dominated the overall market in terms of share at over 40% in 2013. Growing demand for user friendly, relatively smaller and semi-automatically operated devices and the introduction of technological advancements such as robotic guidance systems are some of the major factors attributing to its large share.
Further key findings from the study suggest:
North America dominated the market with a revenue share of over 60.0% in 2013 owing to the presence of sophisticated healthcare infrastructure, reimbursement framework, high healthcare expenditures and growing prevalence of cancer
Europe followed North America in terms of revenue share in 2013 on account of the presence of high patient awareness levels in Western European countries and the presence of large untapped opportunities in Eastern Europe
Asia Pacific is expected to grow at the highest CAGR of over 10.0% during the forecast period. Presence of high unmet medical needs, growing healthcare expenditures and a constantly improving healthcare infrastructure in emerging markets of India and China are some of the factors accounting for its rapid growth.
Key market players include C.R Bard, Care Fusion Corporation, Hologic Inc., Devicor Medical Products Inc., DTR medical, Angiotech, UK Biopsy, Cardinal Healthcare Inc. and INRAD Inc.
For the purpose of this study, Grand View Research has segmented the global biopsy devices market on the basis of products and region:
Biopsy guidance systems dominated the overall market in terms of share at over 40% in 2013. Growing demand for user friendly, relatively smaller and semi-automatically operated devices and the introduction of technological advancements such as robotic guidance systems are some of the major factors attributing to its large share.
Further key findings from the study suggest:
North America dominated the market with a revenue share of over 60.0% in 2013 owing to the presence of sophisticated healthcare infrastructure, reimbursement framework, high healthcare expenditures and growing prevalence of cancer
Europe followed North America in terms of revenue share in 2013 on account of the presence of high patient awareness levels in Western European countries and the presence of large untapped opportunities in Eastern Europe
Asia Pacific is expected to grow at the highest CAGR of over 10.0% during the forecast period. Presence of high unmet medical needs, growing healthcare expenditures and a constantly improving healthcare infrastructure in emerging markets of India and China are some of the factors accounting for its rapid growth.
Key market players include C.R Bard, Care Fusion Corporation, Hologic Inc., Devicor Medical Products Inc., DTR medical, Angiotech, UK Biopsy, Cardinal Healthcare Inc. and INRAD Inc.
For the purpose of this study, Grand View Research has segmented the global biopsy devices market on the basis of products and region:
- Biopsy Devices Product Outlook
- Needle-based Biopsy Guns
- Vacuum-assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) devices
- Biopsy Guidance Systems
- Manual
- Robotic
- Biopsy Needles
- Disposable
- Reusable
- Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
- Others
- Brushes
- Curettes
- Punches
- Biopsy Devices Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Biopsy Devices – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. BIOPSY DEVICES INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Biopsy Devices Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Biopsy Devices - Company Market Share Analysis
2.7. Biopsy Devices Market PESTEL Analysis, 2012
CHAPTER 3. BIOPSY DEVICES PRODUCT OUTLOOK
3.1. Biopsy Guidance system
3.1.1. Global Biopsy guidance systems demand by region, (USD Million), 2012 – 2020
3.1.2. Manual guidance systems market (USD million), 2012 – 2020
3.1.3. Robotic guidance systems market (USD million), 2012 - 2020
3.2. Biopsy Needles
3.2.1. Global Biopsy needles demand by region, (USD Million), 2012 – 2020
3.2.2. Disposable biopsy needles market (USD million), 2012 – 2020
3.2.3. Reusable biopsy needles market (USD million), 2012 - 2020
3.3. Needle-based Biopsy Guns
3.3.1. Global Needle based biopsy guns demand by region, (USD Million), 2012 – 2020
3.3.2. Vacuum assisted biopsy devices market (USD million), 2012 – 2020
3.3.3. Core needle biopsy devices market (USD million), 2012 – 2020
3.3.4. Fine needle aspiration devices market (USD million), 2012 - 2020
3.4. Biopsy Forceps
3.4.1. Global Biopsy forceps demand by region, (USD Million), 2012 – 2020
3.4.2. Cold forceps market (USD million), 2012 – 2020
3.4.3. Hot forceps market (USD million), 2012 - 2020
3.5. Others biopsy devices
3.5.1. Global Other biopsy devices demand by region, (USD Million), 2012 – 2020
3.5.2. Biopsy brushes market (USD million), 2012 – 2020
3.5.3. Biopsy curettes market (USD million), 2012 – 2020
3.5.4. Biopsy punches market (USD million), 2012 - 2020
CHAPTER 4. BIOPSY DEVICES REGIONAL OUTLOOK
4.1. North America
4.1.1. North America biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.2. Europe
4.2.1. Europe biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.3. Asia Pacific
4.3.1. Asia Pacific biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.4. RoW
4.4.1. RoW biopsy devices market revenue by product, (USD Million), 2012 – 2020
CHAPTER 5 BIOPSY DEVICES COMPETITIVE LANDSCAPE
5.1 Angiotech
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Cardinal Health Inc
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Carefusion Corporation
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 C. R. BARD, Inc
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Devicor Medical Products Inc.
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 DTR Medical
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Hologic, Inc
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 INRAD, Inc
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 UK Biopsy
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
CHAPTER 6. METHODOLOGY AND SCOPE
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources
1.1. Biopsy Devices – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. BIOPSY DEVICES INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Biopsy Devices Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Biopsy Devices - Company Market Share Analysis
2.7. Biopsy Devices Market PESTEL Analysis, 2012
CHAPTER 3. BIOPSY DEVICES PRODUCT OUTLOOK
3.1. Biopsy Guidance system
3.1.1. Global Biopsy guidance systems demand by region, (USD Million), 2012 – 2020
3.1.2. Manual guidance systems market (USD million), 2012 – 2020
3.1.3. Robotic guidance systems market (USD million), 2012 - 2020
3.2. Biopsy Needles
3.2.1. Global Biopsy needles demand by region, (USD Million), 2012 – 2020
3.2.2. Disposable biopsy needles market (USD million), 2012 – 2020
3.2.3. Reusable biopsy needles market (USD million), 2012 - 2020
3.3. Needle-based Biopsy Guns
3.3.1. Global Needle based biopsy guns demand by region, (USD Million), 2012 – 2020
3.3.2. Vacuum assisted biopsy devices market (USD million), 2012 – 2020
3.3.3. Core needle biopsy devices market (USD million), 2012 – 2020
3.3.4. Fine needle aspiration devices market (USD million), 2012 - 2020
3.4. Biopsy Forceps
3.4.1. Global Biopsy forceps demand by region, (USD Million), 2012 – 2020
3.4.2. Cold forceps market (USD million), 2012 – 2020
3.4.3. Hot forceps market (USD million), 2012 - 2020
3.5. Others biopsy devices
3.5.1. Global Other biopsy devices demand by region, (USD Million), 2012 – 2020
3.5.2. Biopsy brushes market (USD million), 2012 – 2020
3.5.3. Biopsy curettes market (USD million), 2012 – 2020
3.5.4. Biopsy punches market (USD million), 2012 - 2020
CHAPTER 4. BIOPSY DEVICES REGIONAL OUTLOOK
4.1. North America
4.1.1. North America biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.2. Europe
4.2.1. Europe biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.3. Asia Pacific
4.3.1. Asia Pacific biopsy devices market revenue by product, (USD Million), 2012 – 2020
4.4. RoW
4.4.1. RoW biopsy devices market revenue by product, (USD Million), 2012 – 2020
CHAPTER 5 BIOPSY DEVICES COMPETITIVE LANDSCAPE
5.1 Angiotech
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Cardinal Health Inc
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Carefusion Corporation
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 C. R. BARD, Inc
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Devicor Medical Products Inc.
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 DTR Medical
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Hologic, Inc
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 INRAD, Inc
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 UK Biopsy
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
CHAPTER 6. METHODOLOGY AND SCOPE
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources
LIST OF TABLES
Biopsy Devices – Industry Summary & Critical Success Factors (CSFs)
Global Biopsy Devices market share (USD Million), 2012 - 2020
Global Biopsy Devices market by region (USD Million), 2012 – 2020
Global Biopsy Devices market by product (USD Million), 2012 – 2020
North America Biopsy Devices market by product (USD Million), 2012 – 2020
Europe Biopsy Devices market by product (USD Million), 2012 – 2020
Asia Pacific Biopsy Devices market by product (USD Million), 2012 – 2020
RoW Biopsy Devices market by product (USD Million), 2012 – 2020
Biopsy Devices – Industry Summary & Critical Success Factors (CSFs)
Global Biopsy Devices market share (USD Million), 2012 - 2020
Global Biopsy Devices market by region (USD Million), 2012 – 2020
Global Biopsy Devices market by product (USD Million), 2012 – 2020
North America Biopsy Devices market by product (USD Million), 2012 – 2020
Europe Biopsy Devices market by product (USD Million), 2012 – 2020
Asia Pacific Biopsy Devices market by product (USD Million), 2012 – 2020
RoW Biopsy Devices market by product (USD Million), 2012 – 2020
LIST OF FIGURES
Biopsy Devices Market Segmentation
Global Biopsy Devices market (USD Million), 2012 - 2020
Biopsy Devices value chain analysis
Biopsy Devices market dynamics
Biopsy Devices - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Biopsy Devices PESTEL Analysis, 2013
Biopsy Devices market share by product, 2012 & 2020
Biopsy Devices market share by region, 2012 & 2020
North America Biopsy Devices market, by product (USD Million), 2012 – 2020
Europe Biopsy Devices market, by product (USD Million), 2012 – 2020
Asia Pacific Biopsy Devices market, by product (USD Million), 2012 – 2020
RoW Biopsy Devices market, by product (USD Million), 2012 – 2020
Biopsy Devices Market Segmentation
Global Biopsy Devices market (USD Million), 2012 - 2020
Biopsy Devices value chain analysis
Biopsy Devices market dynamics
Biopsy Devices - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Biopsy Devices PESTEL Analysis, 2013
Biopsy Devices market share by product, 2012 & 2020
Biopsy Devices market share by region, 2012 & 2020
North America Biopsy Devices market, by product (USD Million), 2012 – 2020
Europe Biopsy Devices market, by product (USD Million), 2012 – 2020
Asia Pacific Biopsy Devices market, by product (USD Million), 2012 – 2020
RoW Biopsy Devices market, by product (USD Million), 2012 – 2020
